Erste Asset Management Gmb H Regeneron Pharmaceuticals, Inc. Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

A detailed history of Erste Asset Management Gmb H transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 40,639 shares of REGN stock, worth $29.5 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

40,639

Holding current value

$29.5 Million

% of portfolio

0.51%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $41.6 Million - $48.8 Million	40,639 New	40,639 $42.5 Billion
Q2 2024 Nov 26, 2024	SELL	$883.2 - $1071.19 $2.75 Million - $3.34 Million	-3,115 Reduced 7.43%	38,833 $40.8 Billion
Q1 2024 Nov 26, 2024	BUY	$902.69 - $993.35 $964,072 - $1.06 Million	1,068 Added 2.61%	41,948 $40.5 Billion
Q4 2023 Nov 26, 2024	BUY	$775.18 - $881.7 $1.87 Million - $2.12 Million	2,410 Added 6.26%	40,880 $36 Billion
Q3 2023 Nov 26, 2024	BUY	$692.45 - $844.37 $4.38 Million - $5.34 Million	6,322 Added 19.67%	38,470 $32.1 Billion
Q2 2023 Nov 26, 2024	BUY	$700.03 - $830.35 $289,112 - $342,934	413 Added 1.05%	39,853 $28.2 Billion
Q1 2023 Nov 26, 2024	BUY	$680.49 - $826.97 $3.61 Million - $4.39 Million	5,305 Added 15.54%	39,440 $32 Billion
Q4 2022 Nov 26, 2024	SELL	$705.89 - $766.39 $797,655 - $866,020	-1,130 Reduced 3.4%	32,148 $23.2 Billion
Q3 2022 Nov 26, 2024	SELL	$573.97 - $724.32 $3.73 Million - $4.71 Million	-6,504 Reduced 16.0%	34,135 $23.6 Billion
Q2 2022 Nov 26, 2024	BUY	$548.35 - $738.84 $4.05 Million - $5.45 Million	7,378 Added 28.49%	33,278 $19.9 Billion
Q1 2022 Nov 22, 2024	SELL	$595.12 - $698.43 $1.65 Million - $1.93 Million	-2,769 Reduced 7.92%	32,201 $22.3 Billion
Q4 2021 Nov 22, 2024	SELL	$543.48 - $670.97 $4.01 Million - $4.95 Million	-7,383 Reduced 18.17%	33,256 $21.5 Billion
Q3 2021 Nov 22, 2024	BUY	$574.03 - $680.96 $2.01 Million - $2.38 Million	3,500 Added 11.12%	34,970 $21.2 Billion
Q2 2021 Nov 22, 2024	SELL	$472.8 - $558.54 $780,120 - $921,590	-1,650 Reduced 4.98%	31,470 $17.2 Billion
Q1 2021 Nov 22, 2024	BUY	$446.73 - $548.2 $111,682 - $137,050	250 Added 0.76%	33,120 $15.6 Billion
Q4 2020 Nov 22, 2024	SELL	$478.3 - $607.98 $1.34 Million - $1.7 Million	-2,800 Reduced 7.85%	32,870 $15.9 Billion
Q3 2020 Nov 22, 2024	SELL	$544.75 - $658.21 $2.71 Million - $3.27 Million	-4,969 Reduced 12.23%	35,670 $20.5 Billion
Q2 2020 Nov 22, 2024	BUY	$493.32 - $643.92 $13.1 Million - $17.1 Million	26,500 Added 278.95%	36,000 $22 Billion
Q4 2019 Nov 22, 2024	SELL	$274.13 - $376.51 $8.54 Million - $11.7 Million	-31,139 Reduced 76.62%	9,500 $3.55 Billion
Q2 2019 Nov 22, 2024	SELL	$299.6 - $414.82 $2.35 Million - $3.26 Million	-7,850 Reduced 45.24%	9,500 $2.95 Billion
Q1 2019 Nov 22, 2024	SELL	$372.08 - $439.57 $8.67 Million - $10.2 Million	-23,289 Reduced 57.31%	17,350 $7.02 Billion
Q4 2018 Nov 26, 2024	SELL	$335.82 - $403.04 $4.95 Million - $5.94 Million	-14,739 Reduced 36.27%	25,900 $9.45 Billion

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Regeneron Pharmaceuticals, Inc. Transaction History